These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2741217)

  • 1. Relation between primary tumor shape and biological behavior in breast cancer.
    Giardina C; Ricco R; Lettini T; Gentile A; Serio G; De Benedictis G; Pesce Delfino V
    Tumori; 1989 Apr; 75(2):117-22. PubMed ID: 2741217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nuclear morphometry and estrogen receptors in infiltrating ductal carcinoma of the breast].
    Giardina C; Serio G; Simone G; Pennella A; Vacca E; Ricco R; Scordari D; Pesce Delfino V
    Boll Soc Ital Biol Sper; 1990 Feb; 66(2):135-41. PubMed ID: 2162679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear shape and axillary metastases in breast cancer. Analytic morphometry of aspiration smears.
    Giardina C; Ricco R; Serio G; Vacca E; Pennella A; Renzulli G; Punzo C; Borzacchini AM; Delfino VP
    Acta Cytol; 1994; 38(3):341-6. PubMed ID: 8191823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric discrimination of serous ovarian tumors by analytical morphometry.
    Resta L; Ricco R; Colucci GA; Troia M; Russo S; Vacca E; Varcaccio Garofalo G; Pesce Delfino V
    Eur J Gynaecol Oncol; 1992; 13(1 Suppl):60-4. PubMed ID: 1511716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach to the histologic study of ovarian tumors by analytical morphometry.
    Resta L; Ricco R; Colucci GA; Troia M; Russo S; Vacca E; Pesce Delfino V
    Int J Gynecol Cancer; 1992 Nov; 2(6):307-13. PubMed ID: 11576274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using analytical morphometry to distinguish severe dysplasia and large bowel carcinoma.
    Bufo P; Ricco R; Potente F; Troia M; Serio G; Pesce Delfino V
    Boll Soc Ital Biol Sper; 1990 Feb; 66(2):143-50. PubMed ID: 2357332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear morphometry in node-negative breast carcinoma.
    Giardina C; Renzulli G; Serio G; Caniglia DM; Lettini T; Ferri C; D'Eredità G; Ricco R; Delfino VP
    Anal Quant Cytol Histol; 1996 Oct; 18(5):374-82. PubMed ID: 8908309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Description of the shape of carcinomatous nodules of the breast by means of high degree polynomial equations and Fourier harmonic analysis].
    Ricco R; Giardina C; De Benedictis G; Bufo P; Pesce Delfino V
    Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2135-41. PubMed ID: 6525271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
    Giardina C; Serio G; Lepore G; Lettini T; Dalena AM; Pennella A; D'Eredità G; Valente T; Ricco R
    J Exp Clin Cancer Res; 2003 Jun; 22(2):279-88. PubMed ID: 12866579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurring intracranial meningiomas. Morphometrical evaluation of nuclear pleomorphism by S.A.M. (shape analytical morphometry) system.
    Serio G; Caniglia A; Ferri C; Caniglia DM; Lettini T; Carlucci M; D'Aprile M; Cimmino A; Serio R; Ricco R
    Boll Soc Ital Biol Sper; 1996; 72(5-6):147-53. PubMed ID: 9009052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analytical morphometry of seminiferous tubules in maturation arrest: Fourier analysis of the internal contours of tubules].
    Ricco R; Bufo P; Mitolo V; Pesce Delfino V
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1309-15. PubMed ID: 6548146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size and shape evaluation of astrocytoma nuclei with the shape analytical morphometry software system.
    Ricco R; Serio G; Caniglia DM; Cimmino A; Lettini T; Lozupone A; Delfino VP
    Anal Quant Cytol Histol; 1994 Oct; 16(5):345-50. PubMed ID: 7840840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric analytical evaluators of lymphoid populations in nonneoplastic lymph nodes.
    Ricco R; De Benedictis G; Giardina C; Bufo P; Resta L; Pesce Delfino V
    Anal Quant Cytol Histol; 1985 Dec; 7(4):288-93. PubMed ID: 3841482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear morphology and histological grading of oral squamous cell carcinoma (OSCC). A morphometric study.
    Giardina C; Serio G; Caniglia DM; Lettini T; Ricco R; Renzulli G; Pesce Delfino V
    Boll Soc Ital Biol Sper; 1994; 70(10-11):271-9. PubMed ID: 7702831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
    Yoo J; Kim BS; Chung J; Yoon HJ
    Medicine (Baltimore); 2017 Aug; 96(31):e7657. PubMed ID: 28767583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.
    Janni W; Rack B; Sommer H; Schmidt M; Strobl B; Rjosk D; Klanner E; Thieleke W; Gerber B; Friese K; Dimpfl T
    J Cancer Res Clin Oncol; 2003 Sep; 129(9):503-10. PubMed ID: 12884027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative morphometrical investigation of basal cell layer in laryngeal premalignant lesions.
    Serio G; Giardina C; Valente T; Pennella A; Lettini T; Dalena AM; D'Eredità G; Ricco R; Resta L
    J Exp Clin Cancer Res; 2002 Dec; 21(4):495-502. PubMed ID: 12636095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H; Wei JP; Yeh KA
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers.
    Guarnieri A; Neri A; Correale PP; Lottini M; Testa M; Mariani F; Tucci E; Megha T; Cintorino M; Carli A
    Eur J Surg; 2001 Apr; 167(4):255-9. PubMed ID: 11354316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
    Son SH; Lee SW; Jeong SY; Song BI; Chae YS; Ahn BC; Lee J
    AJR Am J Roentgenol; 2015 Oct; 205(4):878-85. PubMed ID: 26204115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.